PCC

FFP

p

Male (%)

33.3

38.8

0.683

Age (median)

65.6 ± 11.68

67.8 ± 14.54

0.539

BMI (kg/m²) (median)

26.2 + 7.56

27.2 ± 8.27

0.222

CHADSVASC2 (median)

3.28 ± 1.74

3.24 ± 2.05

0.946

HASBLED (median)

1.33 ± 1.16

1.13 ± 0.95

0.822

Mechanical valves (%)

5.9

4.1

0.796

Previous thromboembolic event (%)

27.8

16.3

0.293

Thrombus of LV (%)

11.1

2

0.112

Deep vein thrombosis (%)

11.1

2

0.112

Valvular disease (%)

22.2

24.5

0.847

Atrial fibrilation (%)

66.7

91.8

0.01

Diabetes mellitus (%)

22.2

32.7

0.408

Hypertension (%)

55.5

75.5

0.114

Heart failure (%)

44.4

28.6

0.22

Dyslipidemia (%)

27.8

16.3

0.293

Etilism (%)

0

2

0.541

Tabagism (%)

5.6

16.3

0.252

Previous stroke (%)

22.2

20.4

0.871

Recent surgery (%)

5.6

2

0.454

Previous acute myocardial infarction (%)

22.2

30.6

0.499

Previous gastrointestinal bleeding (%)

0

6.1

0.283

Heart rate (median)

85.2 ± 18.92

83.9 ± 16.45

0.803

Systolic arterial pressure (mmHg) (median)

114.3 ± 23.03

111.6 ± 25.28

0.679

Hemoglobin (mg/dL) (median)

8.78 ± 2.88

10.53 ± 3.23

0.029

Platelets (×10³/mm³) (median)

241 ± 122.34

252 ± 145.67

0.671

INR (median)

12.48 ± 6.88

12.19 ± 7.23

0.007

Creatinin (mg/dL) (median)

1.91 ± 1.05

1.6 ± 1.24

0.932

C-reactive protein (mg/dL) (median)

49.1 ± 67.96

59.7 ± 72.35

0.605

LVEF (%) (median)

47.3 ± 15.29

52.6 ± 13.54

0.228

ml/kg of cristaloids (median)

15.4 ± 8.73

23.1 ± 13.27

0.056

Use of dobutamine (%)

16.7

11.9

0.808

Use of norepinephrine (%)

38.9

8.2

0.003

Aspirin (%)

11.1

24.5

0.233

B-blocker (%)

83.3

69.4

0.254

Proton pump inhibitor (%)

55.6

51

0.742